Literature DB >> 10712994

Exhaled nitric oxide and exercise in stable COPD patients.

E Clini1, L Bianchi, M Vitacca, R Porta, K Foglio, N Ambrosino.   

Abstract

STUDY
OBJECTIVE: To evaluate exhaled nitric oxide (eNO) during exercise in patients with stable COPD.
SETTING: Outpatient evaluation in a rehabilitation center. PATIENTS: Eleven consecutive male patients with stable COPD (age, 65 +/- 6 years; FEV(1), 56 +/- 10% predicted). Eight healthy (six men; age, 51 +/- 16 years) nonsmoking, nonatopic volunteers served as control subjects.
METHODS: In each subject, a symptom-limited cycle ergometry test was performed by monitoring eNO with the tidal-breath method to assess eNO concentration (FENO) and output (VNO) at rest, peak exercise, and recovery time.
RESULTS: Resting FENO (9.8 +/- 5.1 and 14.1 +/- 6.3 parts per billion, respectively) and VNO (4.2 +/- 2.0 and 5.9 +/- 3.4 nmol/min, respectively) were lower, although not significantly, in COPD patients than in control subjects. In both groups, FENO significantly decreased whereas VNO significantly increased during exercise. Both variables returned to baseline during the recovery time. Peak exercise VNO, but not FENO, was significantly lower in COPD patients than in control subjects (7.9 +/- 5.4 and 12.7 +/- 6.0 nmol/min, respectively, p < 0.05). The rise in VNO was weakly correlated to oxygen consumption VO(2)) both in control subjects (r = 0.31, p = 0. 002) and in COPD patients (r = 0.22, p = 0.03). FENO showed an inverse correlation to VO(2) in both groups (r = -0.53, p = 0.000; r = -0.31, p = 0.003 in control subjects and COPD patients, respectively).
CONCLUSIONS: In patients with mild and moderate COPD, eNO during exercise parallels that observed in normal control subjects. VNO, but not FENO, is significantly reduced at peak exercise in COPD patients as compared with control subjects. The long-term effects of exercise training on eNO has to be evaluated by further studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712994     DOI: 10.1378/chest.117.3.702

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

Review 1.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

2.  Effect of pulmonary rehabilitation on exhaled nitric oxide in patients with chronic obstructive pulmonary disease.

Authors:  E Clini; L Bianchi; K Foglio; R Porta; M Vitacca; N Ambrosino
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

3.  Effects of extra-fine inhaled and oral corticosteroids on alveolar nitric oxide in COPD.

Authors:  Philip M Short; Peter A Williamson; Brian J Lipworth
Journal:  Lung       Date:  2012-02-22       Impact factor: 2.584

4.  Exhaled nitric oxide in stable chronic obstructive pulmonary disease.

Authors:  Mohammed F S Beg; Mohammad A Alzoghaibi; Abdullah A Abba; Syed S Habib
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

5.  Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Zhiyu Lu; Weina Huang; Linfeng Wang; Ning Xu; Qunli Ding; Chao Cao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-30

Review 6.  Update on the Mechanisms of Pulmonary Inflammation and Oxidative Imbalance Induced by Exercise.

Authors:  O F Araneda; T Carbonell; M Tuesta
Journal:  Oxid Med Cell Longev       Date:  2016-01-05       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.